Ignite Creation Date:
2025-12-24 @ 6:59 PM
Ignite Modification Date:
2025-12-25 @ 4:32 PM
Study NCT ID:
NCT00315757
Status:
COMPLETED
Last Update Posted:
2013-08-08
First Post:
2006-04-17
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Study of Mapatumumab in Combination With Bortezomib (Velcade) and Bortezomib Alone in Subjects With Relapsed or Refractory Multiple Myeloma
Sponsor:
Human Genome Sciences Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-05
Start Date Type:
None
Primary Completion Date:
2010-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-10
Completion Date Type:
ACTUAL
First Submit Date:
2006-04-17
First Submit QC Date:
None
Study First Post Date:
2006-04-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2011-04-25
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2013-08-01
Last Update Post Date:
2013-08-08
Last Update Post Date Type:
ESTIMATED